ARXS vs. RKLB: Arxis vs. Rocket Lab Stock Comparison

Company Profile

Arxis (ARXS) and Rocket Lab (RKLB) are both classified in the Aerospace & Defense sub-industry within the broader Aerospace & Defense industry, placing them in the closest GICS peer bucket.

Rocket Lab (RKLB) has traded publicly since November 24, 2020, giving it several years of listed trading history, while Arxis (ARXS) only listed on April 16, 2026 and has a limited public-market record.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Rocket Lab (RKLB) is heavily traded at around 19.51M shares per day, whereas Arxis (ARXS) sees a more moderate 885.61K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Both ARXS and RKLB need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Arxis (ARXS) has no ROE value reported for this period; Rocket Lab (RKLB) reports a negative figure of -7.92%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

Rocket Lab (RKLB) reports a negative net margin of -21.51%, usually indicating a net loss over the period. Meanwhile Arxis (ARXS) reports 11.56%, ranking against industry peers normally.

Rocket Lab (RKLB) reports a negative operating margin of -24.57%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Arxis (ARXS) reports 23.66%, ranking against industry peers normally.

Profitability Metrics

Growth

Both companies are growing quickly, but Arxis (ARXS) at 115.49% is the standout with revenue growth above its industry range; Rocket Lab (RKLB) at 37.96% also sits in the top quartile.

Neither Arxis (ARXS) nor Rocket Lab (RKLB) reports a EPS growth value for this period, so a direct comparison isn't possible.

Growth Metrics

Financial Strength

Both Arxis (ARXS) at 4.70 and Rocket Lab (RKLB) at 5.48 post current ratio above their industries’ typical mid-ranges — short-term liquidity appears comfortable, though unusually high readings can point to idle current assets.

Rocket Lab (RKLB) at 0.04 keeps leverage in the lower industry quartile, while Arxis (ARXS) at 0.34 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Neither Arxis (ARXS) nor Rocket Lab (RKLB) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Arxis (ARXS) nor Rocket Lab (RKLB) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Arxis (ARXS) trades at 277.22 times trailing earnings, ranked against its peers, while Rocket Lab (RKLB) has no P/E ratio this period.

Investors are paying well above the peer range per dollar of sales for both Arxis (ARXS) at 11.20 and Rocket Lab (RKLB) at 44.12 — each P/S ratio clears its industry’s benchmark range.

Arxis (ARXS) at 4.02 is valued about in line with its industry on P/B ratio, while Rocket Lab (RKLB) at 9.09 carries an above-peer premium to book — RKLB is pricier on assets.

Valuation Metrics